BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 24064836)

  • 21. [Application and safety of thalidomide in the treatment of multiple myeloma].
    Hattori Y
    Nihon Rinsho; 2007 Dec; 65(12):2296-301. PubMed ID: 18069276
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cell kinetics of multiple myeloma.
    Boccadoro M; Pileri A
    Hematol Pathol; 1987; 1(3):137-42. PubMed ID: 3334345
    [No Abstract]   [Full Text] [Related]  

  • 23. Novel agents and the paradigm of continuous treatment in multiple myeloma.
    Palumbo A
    Leuk Res; 2012 Nov; 36 Suppl 1():S1-2. PubMed ID: 23176718
    [No Abstract]   [Full Text] [Related]  

  • 24. [Multiple myeloma].
    Ozaki S
    Rinsho Ketsueki; 2013 Jan; 54(1):89-99. PubMed ID: 23391652
    [No Abstract]   [Full Text] [Related]  

  • 25. Smoldering multiple myeloma.
    Kyle RA; Greipp PR
    N Engl J Med; 1980 Jun; 302(24):1347-9. PubMed ID: 7374679
    [No Abstract]   [Full Text] [Related]  

  • 26. Normal immunoglobulins in multiple myeloma: effect of melphalan chemotherapy.
    Alexanian R; Migliore PJ
    J Lab Clin Med; 1970 Feb; 75(2):225-33. PubMed ID: 5414404
    [No Abstract]   [Full Text] [Related]  

  • 27. Efficacy and safety of fotemustine for the treatment of relapsed and refractory multiple myeloma patients.
    Mangiacavalli S; Pica G; Varettoni M; Lazzarino M; Corso A
    Eur J Haematol; 2009 Mar; 82(3):240-1. PubMed ID: 19018860
    [No Abstract]   [Full Text] [Related]  

  • 28. Cooperative relationship between pharmaceutical companies, academia, and media explains sharp decrease in frequency of pulmonary complications after bortezomib in Japan.
    Narimatsu H; Hori A; Matsumura T; Kodama Y; Takita M; Kishi Y; Hamaki T; Yuji K; Tanaka Y; Komatsu T; Kami M
    J Clin Oncol; 2008 Dec; 26(35):5820-3. PubMed ID: 19001340
    [No Abstract]   [Full Text] [Related]  

  • 29. Multiple myeloma.
    Hájek R; Krejcí M; Pour L; Adam Z
    Klin Onkol; 2011; 24 Suppl():S10-3. PubMed ID: 21923057
    [TBL] [Abstract][Full Text] [Related]  

  • 30. JSH practical guidelines for hematological malignancies, 2018: III. Myeloma-2. Related disorders of multiple myeloma.
    Iida S; Shimazaki C; Abe M; Nakaseko C
    Int J Hematol; 2019 Jun; 109(6):633-640. PubMed ID: 30963472
    [No Abstract]   [Full Text] [Related]  

  • 31. [IgA multiple myeloma with adverse prognostic factors--a case report].
    Kumiega B; Wolska-Smoleń T; Skotnicki AB
    Przegl Lek; 2009; 66(8):459-63. PubMed ID: 20043594
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment options and considerations for the newly diagnosed myeloma patient.
    Rajkumar VS;
    Oncology (Williston Park); 2005 Sep; 19(10):1260, 1262, 1267 passim. PubMed ID: 16285223
    [No Abstract]   [Full Text] [Related]  

  • 33. Myelomatous pleural effusion.
    Ghosh S; Gopal R; Advani SH
    J Assoc Physicians India; 2006 Sep; 54():738-9. PubMed ID: 17212026
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Determination of the tumor cell mass and its significance as a parameter for prognosis and therapy in patients with multiple myeloma].
    Ludwig H; Schneider K; Pietschmann H
    Acta Med Austriaca; 1978; 5(4-5):164-6. PubMed ID: 756132
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Multiple myeloma].
    Wasastjerna C
    Duodecim; 1974; 90(10):751-64. PubMed ID: 4605799
    [No Abstract]   [Full Text] [Related]  

  • 36. Simultaneous presentation and following remission of chronic lymphocytic leukemia and multiple myeloma.
    Bernardeschi P; Bonechi I; Marchetti G; Puglisi R
    Recenti Prog Med; 1995 Jan; 86(1):25. PubMed ID: 7709037
    [No Abstract]   [Full Text] [Related]  

  • 37. [Treatment of myeloma when high dose therapy is not possible. New drugs--alternatives for elderly patients].
    Mellstedt H; Gimsing P; Waage A
    Lakartidningen; 2011 Oct 19-25; 108(42):2090-4. PubMed ID: 22165535
    [No Abstract]   [Full Text] [Related]  

  • 38. [Treatment for multiple myeloma: current status and future strategy in Japan].
    Iida S
    Rinsho Ketsueki; 2008 Oct; 49(10):1368-73. PubMed ID: 18833921
    [No Abstract]   [Full Text] [Related]  

  • 39. Multiple myeloma presenting as eosinophilic pleural effusion.
    Mehta AA; Venkatakrishnan R; Jose W; Palaniappan M; Pavithran K
    Asia Pac J Clin Oncol; 2010 Dec; 6(4):256-9. PubMed ID: 21114774
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [A case from my practice (2). (Multiple myeloma)].
    Conen D; Vosseler MG; Dubach UC
    Schweiz Rundsch Med Prax; 1979 Oct; 68(42):1373-5. PubMed ID: 118443
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.